目的:我们旨在评估双微导管技术治疗囊状脾动脉瘤的安全性和有效性。
方法:从2013年11月至2020年10月,56例囊状脾动脉瘤患者在我们机构接受了双微导管技术的血管内治疗。技术上的成功定义为动脉瘤腔的栓塞,而没有阻塞父动脉。临床成功定义为没有因脾动脉瘤而死亡,没有再干预,1、6和12个月时复发或器官功能障碍。
结果:技术成功率为100%。未观察到与血管造影或栓塞相关的主要并发症。轻微的并发症包括发烧,疼痛,恶心,13例患者出现轻微并发症。在1个月,临床成功率为96.4%。在6个月和12个月时,临床成功率为92.9%。没有动脉瘤复发或需要再干预。
结论:双微导管技术线圈栓塞治疗囊状脾动脉瘤是一种安全有效的方法,为希望保留其原始血流动力学的患者提供了合理的选择。
OBJECTIVE: We aimed to assess the safety and efficacy of the double microcatheter technique in the treatment of saccular splenic artery aneurysms.
METHODS: From November 2013 to October 2020, 56 patients with saccular splenic artery aneurysms underwent endovascular treatment with the double microcatheter technique at our institution. Technical success was defined as embolization of the aneurysmal cavity with no obstruction of the parent artery. Clinical success was defined as no deaths due to splenic artery aneurysms, and no reintervention, recrudescence or organ dysfunction at 1, 6, and 12 months.
RESULTS: The technical success rate was 100%. No major complications related to angiography or embolization were observed. Minor complications included fever, pain, and nausea, and 13 patients developed minor complications. At 1 month, the rate of clinical success was 96.4%. At 6 and 12 months, the clinical success rate was 92.9%. There were no aneurysmal recurrences or necessities of reintervention.
CONCLUSIONS: Coil embolization with the double microcatheter technique is a safe and effective modality for treating saccular splenic artery aneurysms and offers a reasonable choice for patients who want to retain their original hemodynamics.